Increased Seroreactivity to Glioma-Expressed Antigen 2 in Brain Tumor Patients under Radiation

Sabrina M. Heisel, Ralf Ketter, Andreas Keller et al. · 2008

Read Increased Seroreactivity to Glioma-Expressed Antigen 2 in Brain Tumor Patients under Radiation by Sabrina M. Heisel, Ralf Ketter, Andreas Keller et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002164.txt.

Description

Sabrina Heisel, Ralf Ketter, Andreas Keller, and co-authors measured immune responses in brain tumor patients during radiation, in a 2008 PLOS ONE paper. Gliomas are the most common primary brain tumors, and surgery plus radiation is their standard treatment. Work in cell cultures and animals had hinted that radiation does more than kill tumor cells; it also stirs the immune system.

The team tracked reactivity to an antigen called glioma-expressed antigen 2 in patients under radiation. They found that this response rose during treatment. Signs that radiation wakes up anti-tumor immunity support efforts to pair radiation with immune-based therapies for these hard tumors.

Catalog record

CREATORSabrina M. Heisel, Ralf Ketter, Andreas Keller et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE24 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002164

Browse the full library · About the Tower of Babel